Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Giorgio Walter Canonica(Ospedale Policlinico San Martino), Massimo Triggiani, Nicola Scichilone, Erminia Ridolo, Sarah Barbuto(Mylan (Switzerland)), Giselda Colombo(University of Pavia), Pia Foschino Maria(Mylan (Switzerland)), Diego Bagnasco(Ospedale Policlinico San Martino), Gabriella Guarnieri(Mylan (Switzerland)), Girolamo Pelaia(Magna Graecia University), Giorgio Lorenzo Colombo(University of Pavia), Elisabetta Favero(Mylan (Switzerland)), Chiara Martinotti, Claudia Crimi(Marconi University), Mariangiola Crivellaro, Manuela Latorre(Mylan (Switzerland)), Paolo Solidoro, Marco Caminati, Gianenrico Senna(University of Verona), Pierluigi Paggiaro(University of Pisa), Francesca Puggioni(Humanitas University), Vincenzo Patella(Mylan (Switzerland)), Giovanni Rolla(University of Genoa), Giacomo Matteo Bruno, Caterina Bucca, Francesco Menzella(University of Milan), Eleonora Savi(Pacific Coast University), Enrico Heffler(Humanitas University), Giovanni Passalaqua(University of Genoa), Teresa Costantino Maria(Mylan (Switzerland)), Giuseppe Spadaro(University of Naples Federico II), Stefano Aliberti(Mylan (Switzerland)), Carlo Lombardi, Sergio Di Matteo, Nunzio Crimi(University of Catania), Gianna Camiciottoli, Francesco Blasi(University of Milan)
World Allergy Organization Journal
January 1, 2019
Cited by 119


Related Papers